Norway’s sovereign wealth fund, managed by Norges Bank Investment Management, intends to cut its exposure to U.S. government bonds dramatically. With a total asset base of about $2.3 trillion, the fund will reallocate the proceeds into other bond categories, reflecting a strategic shift in its fixed‑income portfolio.
The Novo Owner foundation, which controls Novo Nordisk, announced a $62 million investment to construct a quantum chip manufacturing plant in Copenhagen, marking a significant European entry into the emerging quantum technology sector.
NBIM suggested an overhaul of its bond portfolio, specifically cutting U.S. Treasury exposure, to boost the returns of Norway’s $2 trillion oil fund, and presented the proposal to the Ministry of Finance.
Strategists forecast that the market for diabetes and obesity treatments will more than double soon, but not all manufacturers will benefit. The article highlights three stocks, including Eli Lilly, that investors can use to bet on the growth of weight‑loss drugs.
European drug makers AstraZeneca, Sanofi and Boehringer Ingelheim backed the AI startup Owkin, providing funding to accelerate its platform that can generate thousands of drug candidates in seconds, hoping to ease drug‑development bottlenecks.
Arquia Banca’s experts provided guidance on which investment funds are expected to deliver the best returns as the new school year begins, suggesting three specific funds for investors to consider.
The world’s largest sovereign wealth fund explained the potential decline of its equity portfolio in different crisis scenarios, information that is also relevant for private investors.
Vanguard introduced a new FTSE Global All Cap ETF that provides exposure to over 10,000 companies worldwide. While the product aims to reduce concentration risk, experts argue that it does not solve the fundamental issues of global ETFs and suggest better alternatives.
A dispute has escalated between German investment house Deutsche Finance and the Bavarian pension fund BVK. Deutsche Finance alleges that BVK made statements that harmed its business and intends to file a lawsuit in the United States. BVK denies the accusations. The conflict centers on millions of euros in losses from a real‑estate investment.
Union Invest Real Estate, a real‑estate fund manager headquartered in Hamburg, announced a strategic overhaul. The firm will now prioritize income from rents instead of relying on property re‑valuation gains, and the reorganisation will lead to job cuts.